
Collegium Pharmaceutical Inc (COLL) Becoming More Attractive for Investors
In a filing, Collegium Pharmaceutical Inc revealed its Former Director Heffernan Michael Thomas acquired Company’s shares for reported $0.33 million
In a filing, Collegium Pharmaceutical Inc revealed its Former Director Heffernan Michael Thomas acquired Company’s shares for reported $0.33 million
Collegium Pharmaceutical Inc’s filing revealed that its Former Director Heffernan Michael Thomas acquired Company’s shares for reported $0.33 million on
Collegium Pharmaceutical Inc’s filing revealed that its Former Director Heffernan Michael Thomas acquired Company’s shares for reported $0.33 million on
Collegium Pharmaceutical Inc’s recent filing unveils that its Former Director Heffernan Michael Thomas acquired Company’s shares for reported $0.33 million
In a filing, Collegium Pharmaceutical Inc revealed its Former Director Heffernan Michael Thomas acquired Company’s shares for reported $24792.0 on
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Collegium Pharmaceutical Inc’s filing revealed that its Director Freund John Gordon unloaded Company’s shares for reported $0.2 million on Jun